Latest Regulatory News

MEC Resources has advanced its investment in Advent Energy and issued shares to directors, while its PEP 11 Joint Venture faces ongoing legal scrutiny ahead of a Federal Court hearing.

Cokal Limited has resumed coal sales to domestic users and advanced critical infrastructure upgrades at its Indonesian metallurgical coal projects, signaling a strategic operational ramp-up amid improving market conditions.

Accent Resources NL continues its methodical progress on the Magnetite Range Project with ongoing pre-feasibility studies and regulatory groundwork, while awaiting key mining lease approvals for its Norseman Gold Project.

Cleo Diagnostics has secured positive FDA feedback and nearly 1,600 biobank samples, accelerating its ovarian cancer blood test development ahead of a planned 2026 U.S. market entry.

NH3 Clean Energy has initiated the FEED phase for its WAH2 clean ammonia project, securing key partnerships and government support while raising $4 million to fuel development.

HeraMED has bolstered its cash position with a $1.98 million capital raise and is on the cusp of finalizing two pivotal U.S. commercial agreements, signaling a major step forward for its digital maternity care platform.

Triton Minerals progresses the sale of its Mozambique graphite assets despite ongoing legal challenges, while initiating exploration at its promising Aucu Gold-Copper Project.

Golden Mile Resources reports standout assay results from its Pearl Copper Project in Arizona and Leonora Gold JV in Western Australia, alongside a successful $490,000 capital raise to fund ongoing exploration.

Freehill Mining shifts focus to cement industry feedstocks, stabilizes operations after plant challenges, and secures fresh capital while reporting promising magnetite test results.

MPR Australia Limited has finalized the sale of its core renewable energy business for approximately $19 million, marking a significant strategic shift. The company now plans to explore options including returning capital to shareholders or acquiring a new business.

Cynata Therapeutics is on track to deliver key clinical trial results in mid-2026 while maintaining a solid cash runway supported by an imminent R&D tax rebate and equity facility.

Heavy Minerals Limited is finalising its Port Gregory Garnet Project Pre-Feasibility Study with a report due in November 2025, while advancing a promising industrial minerals project towards a binding agreement expected this quarter.